Skip to main content
Clinical Trials/TCTR20220810006
TCTR20220810006
Active, not recruiting
Not Applicable

Baseline and the changes of neutrophil-to-lymphocyte ratio throughout chemoradiotherapy in nasopharyngeal cancer

Division of Radiation Oncology, Faculty of Medicine, Chiang Mai University0 sites81 target enrollmentAugust 10, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
asopharyngeal cancer
Sponsor
Division of Radiation Oncology, Faculty of Medicine, Chiang Mai University
Enrollment
81
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2022
End Date
August 19, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Division of Radiation Oncology, Faculty of Medicine, Chiang Mai University

Eligibility Criteria

Inclusion Criteria

  • 1\. age 18\-70 years old
  • 2\. histology\-proven WHO type 2 NPC, stage T2N0M0\-T4N2M0 (AJCC 7th edition)
  • 3\. Eastern Cooperative Oncology Group performance status 0\-1
  • 4\. adequate bone marrow function, and serum creatinine clearance not less than 30 mL per min

Exclusion Criteria

  • N3 or metastatic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials